SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Are there potential problems with generic substitution of antiepileptic drugs? · Study

ReviewAre there potential problems with generic substitution of antiepileptic drugs?

Pamela M Crawford2006

OA

Reviewbronze2006

Are there potential problems with generic substitution of antiepileptic drugs?

Pamela M Crawford · M. Feely · Alan H. Guberman · Günter Krämer

141 citations·0/0 files stored·Seizure

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Epilepsy research and treatment Biosimilars and Bioanalytical Methods

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 141 citations exist upstream.

References

2003Bioequivalence and other unresolved issues in generic drug substitution 2003The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs 1990Assessment [RETIRED]

Cited by

2008Clinical consequences of generic substitution of lamotrigine for patients with epilepsy 2008Generic substitution in the treatment of epilepsy: Patient and physician perceptions 2009CLINICAL CONSEQUENCES OF GENERIC SUBSTITUTION OF LAMOTRIGINE FOR PATIENTS WITH EPILEPSY 2020The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China 2010Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation 2010Switching from Brand‐Name to Generic Psychotropic Medications: A Literature Review 2015Potential Clinical and Economic Impact of Switching Branded Medications to Generics 2013Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2010An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Aucklandarticle · 2 shared references 2007Compulsory Generic Switching of Antiepileptic Drugs: High Switchback Rates to Branded Compounds Compared with Other Drug Classesarticle · 1 shared reference 2006Patients’ attitudes towards and experiences of generic drug substitution in Norwayarticle · 1 shared reference 2008Clinical consequences of generic substitution of lamotrigine for patients with epilepsyarticle · 1 shared reference 2008Generic substitution in the treatment of epilepsy: Patient and physician perceptionsarticle · 1 shared reference 2020The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, Chinaarticle · 1 shared reference

Details

Year2006

Typereview

Published2006-03-01

VenueSeizure

ISSN-L1059-1311

Languageen

Citations141

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.seizure.2005.12.010

openalex_workW2015351537

Links

Imported from OpenAlex (CC0) — nothing here is generated.